Faculty profile
Andrew Rauth
Back to facultyResearch
Read how they describe their research on their University of Toronto profile.
Latest funding
- $62,500
Targeting DNA repair mechanisms by nanoparticles of RNA and radiosensitizer for enhancing treatment of brain metastases of breast cancer
CIHR · 2023 · Co-investigator
- $501,076
Multitargeted Nanomedicine of Synergistic Drug Combinations for Metastatic Breast Cancer Therapy
CIHR · 2019 · Co-investigator
- $512,205
Engineering Transformable Polymer-lipid Nanoparticles for Cascade Drug Delivery to Brain Cancer Cells
CIHR · 2014 · Co-investigator
No publications available.
Targeting DNA repair mechanisms by nanoparticles of RNA and radiosensitizer for enhancing treatment of brain metastases of breast cancer
Principal investigators: Wu, Xiao Yu S
Keywords: Chemotherapy And Radiotherapy ; Translational Research; Tumour Progression And Metastasis
Multitargeted Nanomedicine of Synergistic Drug Combinations for Metastatic Breast Cancer Therapy
Principal investigators: Wu, Xiao Yu S
Keywords: Blood-Brain Barrier Penetrating Nanoparticles; Cd44 Targeting; Integrin Targeting; Invasion And Migration; Metastatic Breast Cancer; Multitargeted Nanomedicine; Synergistic Drug Combination; Targeting Cd44 Pathways
Engineering Transformable Polymer-lipid Nanoparticles for Cascade Drug Delivery to Brain Cancer Cells
Principal investigators: Wu, Xiao Yu S
Keywords: Anticancer Efficacy; Brain Metastases Of Cancer; Cascade Cancer Cell Targeting; Crossing The Blood-Brain Barrier; In Situe Changes Of Particle Size And Shape; In Vivo And In Vitro Imaging; Intracellular Distribution Of Nanoparticles; Polymer And Lipid Composition And Nanostructure; Transformable Nanoparticles; Whole Body And Brain Distribution
Targeted nanoparticle carriers for drug combination therapy of breast cancer
Principal investigators: Wu, Xiao Yu S
Keywords: Biodegradable Nanoparticles; Breast Cancer; Drug Combination Therapy; Metastatic Cancer Cells; Primary Tumor; Rgd Peptide Targeting
New antibody-based approaches to chemotherapy
Principal investigators: Jones, Bryan
From public funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998 with their latest competition results, the Canada Foundation for Innovation, Genome Canada, the Canadian Space Agency, Canada Research Chairs, the Fonds de recherche du Québec, Ontario research funding, Michael Smith Health Research BC, the Canadian Cancer Society, Heart & Stroke and Brain Canada.
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.
Profile data last refreshed on September 29, 2026 from the university directory, publication records and public research funding records.